Skip to content
StockMarketAgent
Healthcare / Medical - Healthcare Information ServicesUpdated 2026-05-10 22:07 UTC

LON/IBAI stock hub

LON/IBAI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/IBAIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.4M
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/IBAI
In the news

Latest news · LON/IBAI

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-112.9
P25 -54.2P50 2.1P75 13.7
ROIC-27.7
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/IBAI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
169
Groups with data
11
Currency
GBP
Showing 169 of 169 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Jersey
Country code
UK
Employees
7
Employees Change
0.1%
Employees Change Percent
1.45
Enterprise value
GBX 1.3M
Exchange
London Stock Exchange
Financial currency
GBP
First seen
2026-05-10
Industry
Medical - Healthcare Information Services
Isin
JE00BD4H0R42
Last refreshed
2026-05-10
Market cap
GBX 1.4M
Price
GBX 0.53
Price currency
GBX
Rev Per Employee
112,592.57x
Sector
Healthcare
Sic
7372
Symbol
lon/IBAI
Website
https://www.imagingbiometrics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-28.26%
EV Earnings
-3.26x
EV/Sales
1.66x
P/B ratio
3.48x
P/S ratio
1.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
-19.93%
EBITDA Margin
-8.37%
Gross margin
93.54%
Gross Profit
GBX 737,272
Gross Profit Growth
6.84%
Gross Profit Growth Q
-11.81%
Gross Profit Growth3 Y
-1.07%
Gross Profit Growth5 Y
5.86%
Net Income
GBX -400,940
Net Income Growth Quarters
2%
Net Income Growth Years
1%
Pretax Margin
-50.87%
Profit Margin
-50.87%
Profit Per Employee
GBX -57,277
ROA
-10.1
Roa5y
-20.81
ROCE
-38.54
ROE
-112.9
Roe5y
-106.3
ROIC
-27.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

12
MetricValue
Cagr1y
-38.26%
Cagr3y
-41.7%
Cagr5y
-40.85%
EPS Growth Quarters
2
EPS Growth Years
1
FCF Growth3 Y
9.03%
OCF Growth3 Y
9.03%
Revenue Growth
5.07x
Revenue Growth Q
-11.31x
Revenue Growth Years
4x
Revenue Growth3 Y
0.74x
Revenue Growth5 Y
6.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

17
MetricValue
Asset Turnover
GBX 0.81
Assets
GBX 1M
Cash
GBX 112,610
Current Assets
GBX 270,861
Current Liabilities
GBX 475,056
Equity
GBX 407,621
Interest Coverage
-67.75
Liabilities
GBX 606,504
Long Term Assets
GBX 743,264
Long Term Liabilities
GBX 131,448
Net Cash
GBX 112,610
Net Cash By Market Cap
GBX 7.94
Net Cash Growth
-61.12%
Net Debt Equity
GBX -0.28
Tangible Book Value
GBX -270,437
Tangible Book Value Per Share
GBX -0
WACC
9.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
0.55
Net Working Capital
GBX -384,006
Quick ratio
0.48
Working Capital
GBX -271,396
Working Capital Turnover
GBX -3.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-8.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-38.24%
200-day SMA
0.69
3Y total return
-80.19%
50-day SMA
0.55
50-day SMA vs 200-day SMA
50under200
5Y total return
-92.76%
All Time High
23.13
All Time High Change
-97.73%
All Time High Date
2020-11-05
All Time Low
0.4
All Time Low Change
31.25%
All Time Low Date
2026-02-03
ATR
0.07
Beta
0.89
Beta1y
2.16
Beta2y
1.24
Ch YTD
-38.24
High
0.64
High52
1.4
High52 Date
2025-11-11
High52ch
-62.5%
Low
0.52
Low52
0.4
Low52 Date
2026-02-03
Low52ch
31.25%
Ma50ch
-4.44%
Price vs 200-day SMA
-24.32%
RSI
51.21
RSI Monthly
39.05
RSI Weekly
45.36
Sharpe ratio
0.33x
Sortino ratio
0.74
Total Return
-8.21%
Tr YTD
-38.24
Tr1m
10.53%
Tr1w
-8.7%
Tr3m
10.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
GBX -157,114
Operating margin
-19.93

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
170,791,846%
Shares Insiders
4.26%
Shares Out
246,709,789
Shares Qo Q
6.52%
Shares Yo Y
8.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

45
MetricValue
Average Volume
565,207.9x
Bv Per Share
0
Ch1m
10.53
Ch1w
-8.7
Ch1y
-38.24
Ch3m
10.53
Ch3y
-80.19
Ch5y
-92.76
Ch6m
-30
Change
-8.7%
Change From Open
0.96
Close
0.58
Days Gap
-9.57
Depreciation Amortization
91,165
Dollar Volume
159,797.9
Earnings Date
2026-05-15
EBIT
GBX -157,114
EBITDA
GBX -65,949
EPS
GBX -0
F Score
3
Financing CF
240,300
Fiscal Year End
December
Founded
1,965
Goodwill
66,280
Investing CF
-255,526
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-06-30
Ma150
0.71
Ma150ch
-26.45%
Ma20
0.59
Ma20ch
-11.74%
Net CF
59,110
Next Earnings Date
2026-05-15
Open
0.52
P OCF Ratio
19.08
Position In Range
4.17
Ppne
752
Price Date
2026-05-08
Relative Volume
0.55x
Revenue
788,148x
SBC By Revenue
10.12x
Share Based Comp
79,757
Tr6m
-30%
Volume
304,377
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/IBAI pay a dividend?

Capital-return profile for this ticker.

Performance

LON/IBAI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-38.2%
S&P 500 1Y: n/a
3Y total return
-80.2%
S&P 500 3Y: n/a
5Y total return
-92.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/IBAI?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
+4.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+8.2%
Negative means the company is buying back shares.
Technical

LON/IBAI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
51.2
Neutral momentum band
Price vs 200-day MA
-24.3%
50/200-day relationship not available
Beta (5Y)
0.89
Moves roughly with the market
Sharpe ratio
0.33
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/IBAI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/IBAI stock rating?

lon/IBAI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/IBAI analysis?

The full report lives at /stocks/lon/IBAI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/IBAI?

The latest report frames lon/IBAI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/IBAI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.